Concord Biotech Limited CC-Dec23.pdf · 2024-02-09
So, the API revenues had like some orders has been spilled over to subsequent months. You expect Q4 to be more than average in API segments.
Okay. And the next question is what would be the sustainable growth rate in the formulation business? Because it has grown like 150% over 9 months, right? Like, what would you expect it to be measured? Because the base is also increased. So, what growth rate you are expecting? So, then maybe one or two quarter view, but maybe one year view or two years view?